These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 11318964

  • 21. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [Abstract] [Full Text] [Related]

  • 22. Interventions for minimal change disease in adults with nephrotic syndrome.
    Palmer SC, Nand K, Strippoli GF.
    Cochrane Database Syst Rev; 2008 Jan 23; 2008(1):CD001537. PubMed ID: 18253993
    [Abstract] [Full Text] [Related]

  • 23. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD001533. PubMed ID: 15674881
    [Abstract] [Full Text] [Related]

  • 24. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD001533. PubMed ID: 17943754
    [Abstract] [Full Text] [Related]

  • 25. Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome.
    Neuhaus TJ, Fay J, Dillon MJ, Trompeter RS, Barratt TM.
    Arch Dis Child; 1994 Dec 17; 71(6):522-6. PubMed ID: 7726612
    [Abstract] [Full Text] [Related]

  • 26. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
    Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
    [Abstract] [Full Text] [Related]

  • 27. In what order should one introduce cyclophosphamide or chlorambucil, cyclosporine or levamisole in a child with steroid-dependent frequently relapsing nephrotic syndrome?
    Brodehl J.
    Pediatr Nephrol; 1993 Oct 27; 7(5):514. PubMed ID: 8251311
    [No Abstract] [Full Text] [Related]

  • 28. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S, Wang Y, Xian L, Toyama T, Jardine M, Li G, Perkovic V, Hong D.
    PLoS One; 2017 Oct 27; 12(9):e0184398. PubMed ID: 28898290
    [Abstract] [Full Text] [Related]

  • 29. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N, Kim S, Craig J, Hodson E.
    Arch Dis Child; 2016 Apr 27; 101(4):404-8. PubMed ID: 26289063
    [Abstract] [Full Text] [Related]

  • 30. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
    Idczak-Nowicka E, Ksiazek J, Kryński J, Wyszyńska T.
    Pediatr Pol; 1996 Aug 27; 71(8):679-83. PubMed ID: 8927471
    [Abstract] [Full Text] [Related]

  • 31. Should cyclosporine replace cytoxan or chlorambucil as the second-line drug for steroid-dependent nephrotic syndrome?
    Brouhard BH.
    Semin Nephrol; 1998 May 27; 18(3):367-9. PubMed ID: 9613881
    [No Abstract] [Full Text] [Related]

  • 32. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A, Perna A, Zamora J, Giuliano GA, Braun N, Remuzzi G.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD004293. PubMed ID: 15495098
    [Abstract] [Full Text] [Related]

  • 33. Immunosuppressive therapy in the nephrotic syndrome in children.
    Trompeter RS.
    Pediatr Nephrol; 1989 Apr 18; 3(2):194-200. PubMed ID: 2701868
    [Abstract] [Full Text] [Related]

  • 34. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
    Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M.
    Clin Nephrol; 2014 Mar 18; 81(3):166-73. PubMed ID: 24361057
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
    Kidney Int; 2019 Jan 18; 95(1):210-218. PubMed ID: 30497684
    [Abstract] [Full Text] [Related]

  • 36. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
    Grupe WE, Makker SP, Ingelfinger JR.
    N Engl J Med; 1976 Sep 30; 295(14):746-9. PubMed ID: 958261
    [Abstract] [Full Text] [Related]

  • 37. Long-term effects of immunosuppressants in steroid-dependent nephrotic syndrome.
    Takeda A, Ohgushi H, Niimura F, Matsutani H.
    Pediatr Nephrol; 1998 Nov 30; 12(9):746-50. PubMed ID: 9874319
    [Abstract] [Full Text] [Related]

  • 38. [Immunity and immunosuppression in childhood idiopathic nephrotic syndrome].
    Frange P, Frey MA, Deschênes G.
    Arch Pediatr; 2005 Mar 30; 12(3):305-15. PubMed ID: 15734130
    [Abstract] [Full Text] [Related]

  • 39. Treatment of membranous nephropathy.
    Ponticelli C, Passerini P.
    Nephrol Dial Transplant; 2001 Mar 30; 16 Suppl 5():8-10. PubMed ID: 11509678
    [Abstract] [Full Text] [Related]

  • 40. Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome.
    Takeda A, Takimoto H, Mizusawa Y, Simoda M.
    Pediatr Nephrol; 2001 Nov 30; 16(11):888-93. PubMed ID: 11685595
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.